# NetEase, Inc.: Form 20-F for the period ended Dec 31, 2021

- Company: [NetEase, Inc.](/companies/ntes.md) (CIK 1110646)
- Form: 20-F
- Filed: 2022-04-28
- Accepted by EDGAR: Apr 28, 2022, 16:03 ET
- Period: 2021-12-31
- Accession: 0001104659-22-052206
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1110646/000110465922052206/ntes-20211231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1110646/000110465922052206/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $13.75bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | $6.38bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | $7.37bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2021-01-01 to 2021-12-31 | $2.21bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | $2.58bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $647.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | $2.66bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | $0.79 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | $0.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 3,367,478,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | $3.91bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $251.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2021-01-01 to 2021-12-31 | $550.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2021-12-31 | $2.28bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $17.75bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $24.11bn | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $7.92bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $8.51bn | us-gaap:Liabilities |
| Long-term debt | at 2021-12-31 | $200.1m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2021-12-31 | $14.96bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2021-12-31 | 3,273,835,376 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1110646/000110465922052206/ntes-20211231x20f.htm

Filed Apr 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-052206. Last ingested by Listed: Nov 6, 2026, 11:02 ET. No prices; not investment advice.